Omada Health Inc
OMDA20.810USD
+0.160+0.77%
Close 11/11, 16:00（ET）Quotes delayed by 15 min
1.20BMarket Cap
LossP/E TTM
More Details of Omada Health Inc Company
Omada Health Inc. is a virtual-first healthcare provider that nurtures lifelong health. The Company has one operating segment, namely all virtual care program product offerings. The Company’s member-facing platform is designed to offer an integrated experience that encompasses the full range of direct interactions. It offers range of programs like Omada for Prevention & Weight Health, Omada for Diabetes, Omada for Hypertension, Omada for musculoskeletal (MSK), and Omada GLP-1 Care Tracks. Its Omada for Prevention & Weight Health programs focus on prediabetes and weight management, two critical elements of preventing diabetes and heart disease. Its Omada for Diabetes program is designed to help members with type 1 or type 2 diabetes achieve stable blood glucose levels and meet and reach their goals for reducing hemoglobin A1C. Its Omada for Hypertension is designed to help reduce members blood pressure and help them maintain healthy blood pressure.
Omada Health Inc Info
Ticker SymbolOMDA
Company nameOmada Health Inc
IPO dateJun 06, 2025
CEOMr. Sean Duffy
Number of employees849
Security typeOrdinary Share
Fiscal year-endJun 06
Address500 Sansome Street
CitySAN FRANCISCO
Stock exchangeNASDAQ Global Select Consolidated
CountryUnited States of America
Postal code94111
Phone18889878337
Websitehttps://www.omadahealth.com/
Ticker SymbolOMDA
IPO dateJun 06, 2025
CEOMr. Sean Duffy
Company Executives of Omada Health Inc
Name
Name/Position
Position
Shareholding
Change
Mr. Wei-Li Shao
Mr. Wei-Li Shao
President
President
576.69K
-0.42%
Mr. Trevor Fetter
Mr. Trevor Fetter
Independent Director
Independent Director
232.65K
+0.31%
Ms. Jeryl Hilleman
Ms. Jeryl Hilleman
Lead Independent Chairman of the Board
Lead Independent Chairman of the Board
210.39K
+0.54%
Mr. Adam Stavisky
Mr. Adam Stavisky
Independent Director
Independent Director
22.92K
--
Ms. Julie D. Klapstein
Ms. Julie D. Klapstein
Independent Director
Independent Director
22.92K
--
Dr. Anne Beal, M.D.
Dr. Anne Beal, M.D.
Independent Director
Independent Director
16.67K
--
Dr. Jonathan D. (Jon) Root, M.D.
Dr. Jonathan D. (Jon) Root, M.D.
Independent Director
Independent Director
894.00
+277.22%
Dr. Sachin H. Jain, M.D.
Dr. Sachin H. Jain, M.D.
Independent Director
Independent Director
--
--
Mr. Steve Cook
Mr. Steve Cook
Chief Financial Officer
Chief Financial Officer
--
--
Mr. Sean Duffy
Mr. Sean Duffy
Chief Executive Officer, Co-Founder, Director
Chief Executive Officer, Co-Founder, Director
--
--
Name
Name/Position
Position
Shareholding
Change
Mr. Wei-Li Shao
Mr. Wei-Li Shao
President
President
576.69K
-0.42%
Mr. Trevor Fetter
Mr. Trevor Fetter
Independent Director
Independent Director
232.65K
+0.31%
Ms. Jeryl Hilleman
Ms. Jeryl Hilleman
Lead Independent Chairman of the Board
Lead Independent Chairman of the Board
210.39K
+0.54%
Mr. Adam Stavisky
Mr. Adam Stavisky
Independent Director
Independent Director
22.92K
--
Ms. Julie D. Klapstein
Ms. Julie D. Klapstein
Independent Director
Independent Director
22.92K
--
Dr. Anne Beal, M.D.
Dr. Anne Beal, M.D.
Independent Director
Independent Director
16.67K
--
Revenue Breakdown
No Data
No Data
By Business
By Region
No Data
Shareholding Stats
Updated: Tue, Nov 11
Updated: Tue, Nov 11
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
Fidelity Management & Research Company LLC
9.65%
Revelation Partners, LLC
8.99%
U.S. Venture Partners
8.15%
Andreessen Horowitz
7.97%
CIGNA Investments, Inc.
5.95%
Other
59.30%
Shareholders
Shareholders
Proportion
Fidelity Management & Research Company LLC
9.65%
Revelation Partners, LLC
8.99%
U.S. Venture Partners
8.15%
Andreessen Horowitz
7.97%
CIGNA Investments, Inc.
5.95%
Other
59.30%
Shareholder Types
Shareholders
Proportion
Investment Advisor
29.18%
Venture Capital
26.51%
Hedge Fund
7.64%
Corporation
6.85%
Individual Investor
5.98%
Investment Advisor/Hedge Fund
5.65%
Private Equity
4.19%
Research Firm
1.17%
Sovereign Wealth Fund
0.52%
Other
12.30%
Institutional Shareholding
Updated: Wed, Jul 2
Updated: Wed, Jul 2
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2025Q3
102
42.92M
74.14%
+40.88M
2025Q2
26
34.04M
59.80%
+34.04M
Shareholder Activity
Name
Shares Held
Proportion
Change
Chg %
Date
Fidelity Management & Research Company LLC
5.59M
9.7%
+5.59M
--
Jun 30, 2025
Revelation Partners, LLC
5.21M
9.05%
+5.21M
--
Jun 30, 2025
U.S. Venture Partners
4.72M
8.19%
+4.72M
--
Jun 30, 2025
Andreessen Horowitz
4.61M
8.01%
+4.61M
--
Jun 30, 2025
Cigna Ventures LLC
3.44M
5.98%
+3.44M
--
Jun 06, 2025
aMoon Fund
2.70M
4.7%
+2.70M
--
Jun 06, 2025
Norwest Venture Partners
2.53M
4.4%
+2.53M
--
Jun 30, 2025
Perceptive Advisors LLC
2.43M
4.21%
+2.43M
--
Jun 30, 2025
Duffy (Sean P M.D.)
2.01M
3.49%
-4.41K
-0.22%
Sep 05, 2025
View more
Related ETFs
Updated: Thu, Nov 6
Updated: Thu, Nov 6
Name
Proportion
Goldman Sachs Innovate Equity ETF
0.07%
iShares Russell 2000 ETF
0.01%
Global X Russell 2000 ETF
0.01%
Proshares Ultra Russell 2000
0.01%
ProShares Hedge Replication ETF
0.01%
iShares Russell 2000 Value ETF
0.01%
Fidelity Nasdaq Composite Index ETF
0.01%
ProShares UltraPro Russell2000
0.01%
iShares Russell 2000 Growth ETF
0.01%
Schwab U.S. Small-Cap ETF
0%
View more
Goldman Sachs Innovate Equity ETF
Proportion0.07%
iShares Russell 2000 ETF
Proportion0.01%
Global X Russell 2000 ETF
Proportion0.01%
Proshares Ultra Russell 2000
Proportion0.01%
ProShares Hedge Replication ETF
Proportion0.01%
iShares Russell 2000 Value ETF
Proportion0.01%
Fidelity Nasdaq Composite Index ETF
Proportion0.01%
ProShares UltraPro Russell2000
Proportion0.01%
iShares Russell 2000 Growth ETF
Proportion0.01%
Schwab U.S. Small-Cap ETF
Proportion0%
Dividend
A total of
0.00
USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
No Data
Stock Split
Date
Type
Ratio
No Data
Date
Type
Ratio
No Data
